Inhalation Therapy in Ambulant and Hospitalized Patient Using Available Film Sequences From the Internet
Launched by RWTH AACHEN UNIVERSITY · Mar 15, 2017
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • male and female patients indicated for inhalative treatment with ß2-mimetics, inhalative steroids, anticholinergic drugs, or a combination of these drugs
- • patient was already trained on how to use the inhalator before participating in the study
- • age \> 18
- • obtained written consent
- Exclusion Criteria:
- • patients who are incapable to consent or are unable to understand the scope of the trial
- • patients who indicate that they do not know how to use the inhalator
About Rwth Aachen University
RWTH Aachen University is a prestigious research institution located in Aachen, Germany, renowned for its commitment to advancing science and technology through innovative research and education. As a clinical trial sponsor, RWTH Aachen University leverages its interdisciplinary expertise and state-of-the-art facilities to conduct cutting-edge clinical research aimed at improving patient outcomes. The university collaborates with various healthcare stakeholders to facilitate the translation of scientific discoveries into effective therapeutic interventions, ensuring adherence to ethical standards and regulatory requirements throughout the research process. With a focus on fostering knowledge exchange and driving clinical advancements, RWTH Aachen University plays a pivotal role in shaping the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aachen, Nrw, Germany
Patients applied
Trial Officials
Tobias Müller, PD Dr. med.
Principal Investigator
University Hospital, Aachen
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials